跳至主要内容
临床试验/NCT03130010
NCT03130010已完成不适用

The Effect of Nefopam on Catheter-related Bladder Discomfort: A Double-blind, Randomized, Controlled, Parallel Design Study

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2017年3月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
catheter-related bladder discomfort

研究概览

简要总结

In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site,
  • Adults 20 to 75years of age
  • American Society of Anesthesiologists Physical Classification 1,2 patients
  • Patients who pre-agreed to the study
  • Male patient

排除标准

  • Neurogenic bladder
  • Patients diagnosed with irritable bladder
  • study drug sensitive or contraindicated
  • Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor)
  • Patients with urethral and prostate disorders
  • Patients with previous history of myocardial infarction
  • Patients with closed angle glaucoma

研究组 & 干预措施

The control group

Placebo Comparator

One hour before the end of the operation, the control group was received 20 ml of saline.

干预措施: Nefopam or saline (Drug)

The Nefopam group

Active Comparator

One hour before the end of the operation, the Nefopam group was received 20 mg of nefopam.

干预措施: Nefopam or saline (Drug)

结局指标

主要结局

catheter-related bladder discomfort

时间窗: postoperative 1 hour

assessment of catheter-related bladder discomfort using visual analogue scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验